RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+14.16%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$249M
AUM Growth
+$249M
(+3%)
Cap. Flow
+$11.8K
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$11.8K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $162M | 63.94% |
1,111,111
| – | – |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $46.8M | 18.49% |
31,841,394
+8,060
| +0% | +$11.8K |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $40.7M | 16.07% |
3,846,154
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $18K | 0.01% |
3,700
| – | – |
|